BrainCells will use its technology to find neuroscience applications for drugs in Organon’s pipeline.
BrainCells and Organon will collaborate in the discovery and development of drugs for the treatment of central nervous system disorders.

BrainCells will use its technology in the area of neurogenesis to identify neuroscience applications for compounds formerly in the Organon clinical-stage pipeline. When BrainCells determines the therapeutic utility for a drug candidate, the companies will work together to develop and reposition the drug for its new use.

Previous articleNCI Purchases Site License for Agilent Bioinformatics Solutions
Next articleCelldex Therapeutics and LICR Sign Cancer Antigen License and Research Agreement